These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6957896)

  • 21. Effect of desipramine on dopamine receptor binding in vivo.
    Suhara T; Inoue O; Kobayasi K
    Life Sci; 1990; 47(23):2119-26. PubMed ID: 2266782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M; Vrsecká M; Krejcí I; Dlabac A
    Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 26. MIF-I and postsynaptic receptor sites for dopamine.
    Kostrzewa RM; Hardin JC; Snell RL; Kastin AJ; Coy DH; Bymaster F
    Brain Res Bull; 1979; 4(5):657-62. PubMed ID: 39665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction of simple tetrahydroisoquinolines with opiate and high-affinity dopamine (D3) receptors in the rat corpus striatum].
    Patsenko AA; Grinevich VP; Ostrovskiĭ IuM
    Farmakol Toksikol; 1987; 50(4):33-5. PubMed ID: 2822473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The release of 3H-dopamine by nomifensine in rat striatal tissue slices.
    Huff MR; Meadows GG; Johnson WE
    Res Commun Chem Pathol Pharmacol; 1986 Sep; 53(3):403-6. PubMed ID: 3775107
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
    Seeman P; Grigoriadis D
    Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
    [No Abstract]   [Full Text] [Related]  

  • 32. Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment.
    Bischoff S; Bittiger H; Krauss J; Vassout A; Waldmeier P
    Eur J Pharmacol; 1984 Sep; 104(1-2):173-6. PubMed ID: 6437847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
    Martin-Iverson MT; Leclere JF; Fibiger HC
    Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP; Zahniser NR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V; Nielsen M
    Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.
    McKillop D; Bradford HF
    Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK; Hietala J; Röyttä M; Grönroos J
    Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS; Runice C
    Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.